Berna Biotech shareholders created the prerequisite to accept the public exchange offer of Crucell
13-Jan-2006
The Board of directors again encouraged the shareholders to accept the public offer of Crucell. The time limit for tendering the shares will expire on January 20, 2006.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.